Two of the four cases are in Lubbock, which hasn’t seen a case in more than 20 years. Meanwhile, measles vaccination rates in ...
Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...